TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/10/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consist of the teal stylized wording "HUB" and a stylized outline design of cells in shades of teal. The white inside the cells is background only and is not claimed as a feature of the mark.
Titulares
Representantes
William C. Wright Epstein Drangel LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Cells, stem cells, epithelial cells, all for scientific research purposes; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures, for scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic preparations and reagents for use in science; chemicals used in science and industry; assays and assay reagents for scientific purposes; cell culture media for scientific research purposes
Classe 5
Cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; stem cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; stem cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; epithelial cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; epithelial cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary diagnostic and therapeutic purposes namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary diagnostic and therapeutic purposes namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cell cultures for medical and veterinary diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cell cultures for medical and veterinary diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; diagnostic and analytical preparations for medical purposes; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cells, cultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx
Classe 42
Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compound, drug and vaccine discovery, development services, and characterization and validation services in the nature of product quality and efficacy testing for medical compounds, drugs and vaccines; candidate drug and vaccine, drug and vaccine testing services, namely, testing of pharmaceuticals; companion diagnostics, namely, the scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine
Classe 44
Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services
Histórico de despachos e eventos da marca no USPTO.
53 publicações encontradas
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/10/2025
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
28/10/2025
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/10/2025
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/10/2025
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/10/2025
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/10/2025
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/05/2025
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/05/2024
CHANGE OF OWNER RECEIVED FROM IB
05/04/2024
FINAL DECISION TRANSACTION PROCESSED BY IB
03/10/2020
FINAL DISPOSITION NOTICE SENT TO IB
15/09/2020
FINAL DISPOSITION PROCESSED
15/09/2020
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/08/2020
REGISTERED-PRINCIPAL REGISTER
12/05/2020
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/02/2020
PUBLISHED FOR OPPOSITION
25/02/2020
NOTIFICATION PROCESSED BY IB
22/02/2020
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/02/2020
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/02/2020
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/02/2020
APPROVED FOR PUB - PRINCIPAL REGISTER
22/01/2020
EXAMINER'S AMENDMENT ENTERED
22/01/2020
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/01/2020
EXAMINERS AMENDMENT E-MAILED
22/01/2020
EXAMINERS AMENDMENT -WRITTEN
22/01/2020
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/01/2020
NOTIFICATION PROCESSED BY IB
17/01/2020
PREVIOUS ALLOWANCE COUNT WITHDRAWN
14/01/2020
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/01/2020
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/01/2020
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/01/2020
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
ASSIGNED TO LIE
19/12/2019
APPROVED FOR PUB - PRINCIPAL REGISTER
17/12/2019
EXAMINER'S AMENDMENT ENTERED
17/12/2019
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17/12/2019
EXAMINERS AMENDMENT E-MAILED
17/12/2019
EXAMINERS AMENDMENT -WRITTEN
17/12/2019
TEAS/EMAIL CORRESPONDENCE ENTERED
05/12/2019
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/12/2019
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/12/2019
NEW REPRESENTATIVE AT IB RECEIVED
01/08/2019
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/07/2019
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/07/2019
REFUSAL PROCESSED BY IB
28/06/2019
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/06/2019
REFUSAL PROCESSED BY MPU
10/06/2019
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/05/2019
NON-FINAL ACTION WRITTEN
28/05/2019
APPLICATION FILING RECEIPT MAILED
14/05/2019
ASSIGNED TO EXAMINER
10/05/2019
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/05/2019
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/05/2019
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.